Vimarsana
Biggest News Aggregation in the World

Page 47 - Technology Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Partners Today - Breaking & Trending Today

MercadoLibre (MELI) Q1 2024 Earnings Call Transcript - Vimarsana News

MercadoLibre (MELI) Q1 2024 Earnings Call Transcript

MELI earnings call for the period ending March 31, 2024.

Source: fool.com
StockNews.com Initiates Coverage on WidePoint (NYSEAMERICAN:WYY) - Vimarsana News

StockNews.com Initiates Coverage on WidePoint (NYSEAMERICAN:WYY)

StockNews.com started coverage on shares of WidePoint (NYSEAMERICAN:WYY – Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the technology company’s stock. WidePoint Stock Performance Shares of WYY stock opened at $2.08 on Monday. The company has a market cap of $19.88 million, a P/E ratio of -4.52 […]

Amgen (NASDAQ:AMGN) Shares Gap Up Following Earnings Beat - Vimarsana News

Amgen (NASDAQ:AMGN) Shares Gap Up Following Earnings Beat

Amgen Inc. (NASDAQ:AMGN – Get Free Report)’s stock price gapped up before the market opened on Friday following a stronger than expected earnings report. The stock had previously closed at $278.39, but opened at $313.39. Amgen shares last traded at $313.33, with a volume of 4,053,898 shares trading hands. The medical research company reported $3.96 […]

Amgen (NASDAQ:AMGN) PT Raised to $307.00 at UBS Group - Vimarsana News

Amgen (NASDAQ:AMGN) PT Raised to $307.00 at UBS Group

Amgen (NASDAQ:AMGN – Get Free Report) had its price objective boosted by equities research analysts at UBS Group from $284.00 to $307.00 in a report released on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical research company’s stock. UBS Group’s price target would indicate a potential downside of 0.90% from […]

722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC - Vimarsana News

722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC

McAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 722 shares of the medical research company’s stock, valued at approximately $208,000. A number of other hedge funds also […]